TheNote
FDA approves updated drug labe... Note
GooglePlay AppStore
FDA | What's New

FDA approves updated drug labeling for fludarabine phosphate under Project Renewal

On November 19, 2024, the FDA approved updated drug labeling for fludarabine phosphate (Fludarabine Phosphate Injection, Sandoz) under Project Renewal, an Oncology Center of Excellence (OCE) initiative aimed at updating labeling information for certain older oncology drugs.
http://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-updated-drug-labeling-fludarabine-phosphate-under-project-renewal fda.gov
RSS Hunter RSS Hunter • Nov 20, 2024